Please find attached herewith the Intimation under Regulation 30 of SEBI LODR Regulations, 2015

19th October, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code:533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) With reference to the captioned matter, we wish to inform you that Alembic Global Holding SA, a Wholly Owned Subsidiary (‘WOS’) of the Company, has incorporated its WOS named Alvesta Pharmaceuticals FZCO in Dubai, United Arab Emirates, on 1st September, 2026. The intimation regarding the incorporation of the said WOS was received by the Company on 19th October, 2026. The details required to be disclosed under in this regard as per Regulation 30 of the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 (‘Master Circular’), are enclosed herewith as Annexure – I. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary Encl: A/a ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 Annexure-I The details required to be disclosed under Regulation 30 of Listing Regulations, as specified in Clause 1.1.A of Annexure-18 of the Master Circular: Particulars Details i. Name of the entity, date & Name of the entity: Alvesta Pharmaceuticals country of incorporation, etc.; FZCO Date of Incorporation: 1st September, 2026 Country of Incorporation: United Arab Emirates ii. Name of holding company of Name of the Holding Company: Alembic the incorporated company Global Holding SA (“AGH”), a WOS of the and relation with the listed Company. entity Relation with the Company: Step Down Wholly Owned Subsidiary iii. Industry to which the entity Pharmaceuticals being incorporated belongs; iv. Brief background about the To explore new business opportunities and to entity incorporated in terms promote, sale and distribute pharmaceutical of products / line of product(s) of the Company. business v. Brief details of any Not Applicable governmental or regulatory approvals required for the incorporation; vi. Nature of consideration - Cash consideration whether cash consideration or share swap and details of the same vii. Cost of subscription / price at Cost of Subscription: AED 100,000 (Arab which the shares are Emirates Dirham One Lakh Only). subscribed Price: 100 shares of AED 1,000 each are subscribed by AGH. viii. Percentage of shareholding / Percentage of control: 100% through AGH. control by the listed entity and / or number of shares allotted No. of shares allotted: 100 shares of AED 1,000 each issued to AGH. ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123